NeuBase Therapeutics (NBSE) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free NBSE Stock Alerts $0.38 -0.01 (-2.58%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Down 36.3% in Aprilamericanbankingnews.com - May 11 at 2:02 AMNeuBase Therapeutics to delist from Nasdaq next weekbizjournals.com - May 6 at 3:40 PMNeuBase Therapeutics, Inc.: NeuBase Therapeutics Announces Receipt of Notice from Nasdaqfinanznachrichten.de - April 6 at 8:58 AMNeuBase Therapeutics Announces Receipt of Notice from Nasdaqglobenewswire.com - April 5 at 4:05 PMWhy Neubase Therapeutics (NBSE) Shares Are Nosedivingmsn.com - March 27 at 10:32 AMNeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare moversmsn.com - March 26 at 10:47 AMWhy Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?investorplace.com - March 26 at 9:08 AMNeuBase Therapeutics sets shareholder meeting on dissolution planbizjournals.com - March 25 at 7:44 PMNeuBase Therapeutics Incedition.cnn.com - February 26 at 9:46 AMNeuBase Therapeutics, Inc. (NBSE)finance.yahoo.com - February 20 at 1:40 PMNeuBase Therapeutics Inc (O7P.BE)ca.finance.yahoo.com - January 20 at 12:17 AMCMU halts licensing agreement with NeuBase Therapeuticsbizjournals.com - December 22 at 7:16 PMmarketbeat.com - November 30 at 2:54 PMmarketbeat.com - November 30 at 1:27 PMmarketbeat.com - November 30 at 1:18 PMmarketbeat.com - November 30 at 1:13 PMmarketbeat.com - November 30 at 10:26 AMmarketbeat.com - November 30 at 10:18 AMPsychemedics Corporation Appoints Daniella Mehalik as VP - Financefinance.yahoo.com - November 27 at 10:19 AMNeuBase Therapeutics Inc NBSEmorningstar.com - November 6 at 11:41 PMNeuBase Therapeutics, Inc. (NBSE.MX)finance.yahoo.com - October 6 at 8:56 AMMassive Insider Trade At NeuBase Therapeuticsbenzinga.com - September 12 at 3:51 PMNeuBase falls after largest shareholder disposes of part stakemsn.com - September 12 at 3:51 PMNeuBase Therapeutics Issues Statement Regarding Filing By Shareholderfinance.yahoo.com - September 8 at 11:10 AMWhy Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?markets.businessinsider.com - September 6 at 9:07 AMAnalysts Conflicted on These Healthcare Names: NeuBase Therapeutics (NBSE) and Centessa Pharmaceuticals (CNTA)markets.businessinsider.com - August 16 at 7:45 AMNeuBase Therapeutics (NASDAQ: NBSE)fool.com - August 6 at 6:46 PMNeuBase Therapeutics to Explore Strategic Alternativesfinance.yahoo.com - August 3 at 11:30 AMPittsburgh biotech firm amends stock incentive planbizjournals.com - August 1 at 9:57 PMNeuBase Announces Closing of $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - June 30 at 5:50 PMNeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to Redosingfinance.yahoo.com - June 29 at 10:04 AMNeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - June 28 at 6:09 PMNeuBase Therapeutics, Inc.: NeuBase Announces 1-for-20 Reverse Stock Splitfinanznachrichten.de - June 14 at 10:15 AMNeuBase Therapeutics to undertake 1-for-20 reverse share splitmsn.com - June 14 at 10:15 AMNeuBase Announces 1-for-20 Reverse Stock Splitfinance.yahoo.com - June 14 at 10:15 AMNeuBase to Participate in Jefferies Healthcare Conferencefinance.yahoo.com - May 24 at 1:06 PMNeuBase Releases Promising Preclinical Data From Stealth Editors To Achieve Gene Editingmsn.com - May 22 at 3:27 PMNeuBase Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors™finance.yahoo.com - May 22 at 10:27 AMNeuBase Announces Formation of Gene Editing Advisory Boardfinance.yahoo.com - May 16 at 4:27 PMNeuBase Therapeutics, Inc.: NeuBase Reports Business Update and Financial Results for the First Quarter of 2023finanznachrichten.de - May 12 at 8:52 AMNeuBase Therapeutics GAAP EPS of -$0.12 misses by $0.02msn.com - May 11 at 8:37 PMNeuBase Reports Business Update and Financial Results for the First Quarter of 2023finance.yahoo.com - May 11 at 8:37 PMNeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meetingfinance.yahoo.com - May 2 at 8:25 PMWhy MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarketmsn.com - April 20 at 9:22 AMWhy Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarketmsn.com - March 27 at 10:20 AMNeuBase Therapeutics, Inc.: NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023finanznachrichten.de - February 15 at 12:51 PMNeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023finance.yahoo.com - February 14 at 8:40 PMNeuBase Therapeutics selling stake in company to New York investment firm Alumni Capitalfinance.yahoo.com - December 29 at 7:25 PMNeuBase Therapeutics, Inc.: NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2022finanznachrichten.de - December 21 at 1:54 PMNeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2022nz.finance.yahoo.com - December 21 at 8:53 AM Get NeuBase Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NBSE and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide NBSE Media Mentions By Week NBSE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBSE News Sentiment▼0.970.56▲Average Medical News Sentiment NBSE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBSE Articles This Week▼40▲NBSE Articles Average Week Get NeuBase Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NBSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INM News Today LSDI News Today PBLA News Today ATNF News Today BDRX News Today GRI News Today PRFX News Today ALLR News Today QLGN News Today PXMD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBSE) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmith[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuBase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
